AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PLUS THERAPEUTICS, INC. Director's Dealing 2015

Feb 13, 2015

Director's Dealing

Opens in your device viewer

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2015-02-13

Reporting Person: Naughton Gail K (Director)

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-02-13	Incentive Stock Option (Right to Buy)	$0.47	A	25000	Acquired	2025-02-13	Common Stock (25000)	Direct

Security	Shares	Ownership
Restricted Stock Award	21000	Direct

F1: The Restricted Stock vests 50% on July 1, 2015 and 50% on July 1, 2016, subject to Dr. Naughton's continued service to the Company.

F2: The stock options vest 1/12th each month from date of grant, subject to the terms of the Company's 2014 Equity Incentive Plan.